FDA Approved: LATANOPROST — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for LATANOPROST from Sandoz Inc (AP), marking regulatory approval for this generic glaucoma therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

SUPPL AP for LATANOPROST (LATANOPROST)